SI-BONE, Inc. (SIBN)
After hours:
| Previous Close | 15.42 |
| Open | 15.42 |
| Bid | 15.54 x 300 |
| Ask | 15.61 x 300 |
| Day's Range | 15.18 - 15.64 |
| 52 Week Range | 14.84 - 29.51 |
| Volume | |
| Avg. Volume | 429,683 |
| Market Cap | 638.964M |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May 6, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by register
- GlobeNewswire
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami. Management will be hosting a fireside chat on Tuesday, March 12, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Investors interested in listening to the conference call may do so
- GlobeNewswire
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights (all comparisons are to the prior year period) Worldwide revenue of $38.9 million, representing an increase of ~22%U.S. revenue of $36.7 million, representing an increase of ~22%Gross Margi
